chr12-112828349-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001143854.2(RPH3A):c.31A>G(p.Asn11Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
RPH3A
NM_001143854.2 missense
NM_001143854.2 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 2.66
Genes affected
RPH3A (HGNC:17056): (rabphilin 3A) The protein encoded by this gene is thought to be an effector for RAB3A, which is a small G protein that acts in the late stages of neurotransmitter exocytosis. The encoded protein may be involved in neurotransmitter release and synaptic vesicle traffic. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08779511).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPH3A | NM_001143854.2 | c.31A>G | p.Asn11Asp | missense_variant | 3/22 | ENST00000389385.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPH3A | ENST00000389385.9 | c.31A>G | p.Asn11Asp | missense_variant | 3/22 | 1 | NM_001143854.2 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.31A>G (p.N11D) alteration is located in exon 3 (coding exon 1) of the RPH3A gene. This alteration results from a A to G substitution at nucleotide position 31, causing the asparagine (N) at amino acid position 11 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;T;T;.;T;T;.;T;T;T;T;T;.;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T;.;.;T;T;T;T;T;.;T;T;.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;N;.;.;.;.;.;.;.;.;N;.;N;N;.;.
MutationTaster
Benign
N;N;N;N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;D;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;T;T;T;T;.;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;.;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
.;.;.;B;.;.;.;.;.;.;.;.;B;.;B;B;.;B
Vest4
0.19, 0.19, 0.21, 0.27
MutPred
Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);Gain of catalytic residue at R12 (P = 0.0013);
MVP
MPC
0.31
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at